Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

1.

Development of HIV-1 rectal-specific microbicides and colonic tissue evaluation.

Dezzutti CS, Russo J, Wang L, Abebe KZ, Li J, Friend DR, McGowan IM, Rohan LC.

PLoS One. 2014 Jul 15;9(7):e102585. doi: 10.1371/journal.pone.0102585. eCollection 2014.

PMID:
25025306
[PubMed - in process]
Free PMC Article
2.

Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection.

McConville C, Boyd P, Major I.

Clin Med Insights Womens Health. 2014 Feb 13;7:1-8. doi: 10.4137/CMWH.S10353. eCollection 2014. Review.

PMID:
24741339
[PubMed]
Free PMC Article
3.

Cultivated vaginal microbiomes alter HIV-1 infection and antiretroviral efficacy in colonized epithelial multilayer cultures.

Pyles RB, Vincent KL, Baum MM, Elsom B, Miller AL, Maxwell C, Eaves-Pyles TD, Li G, Popov VL, Nusbaum RJ, Ferguson MR.

PLoS One. 2014 Mar 27;9(3):e93419. doi: 10.1371/journal.pone.0093419. eCollection 2014.

PMID:
24676219
[PubMed - in process]
Free PMC Article
4.

Who will Benefit from a Wide-Scale Introduction of Vaginal Microbicides in Developing Countries?

Dimitrov DT, Masse B, Boily MC.

Stat Commun Infect Dis. 2010 Jan;2(1):1012.

PMID:
24490001
[PubMed]
Free PMC Article
5.

Clinical use of vaginal or rectally applied microbicides in patients suffering from HIV/AIDS.

Gupta SK, Nutan.

HIV AIDS (Auckl). 2013 Oct 22;5:295-307. doi: 10.2147/HIV.S39164. Review.

PMID:
24174883
[PubMed]
Free PMC Article
6.

Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis.

Chaowanachan T, Krogstad E, Ball C, Woodrow KA.

PLoS One. 2013 Apr 22;8(4):e61416. doi: 10.1371/journal.pone.0061416. Print 2013.

PMID:
23630586
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Self-delivery multifunctional anti-HIV hydrogels for sustained release.

Li J, Li X, Kuang Y, Gao Y, Du X, Shi J, Xu B.

Adv Healthc Mater. 2013 Dec;2(12):1586-90. doi: 10.1002/adhm.201300041. Epub 2013 Apr 25.

PMID:
23616384
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Biomedical approaches to HIV prevention.

Mayer KH, Skeer M, Mimiaga MJ.

Alcohol Res Health. 2010;33(3):195-202.

PMID:
23584061
[PubMed - in process]
Free PMC Article
9.

Evaluation of the lymphocyte trafficking drug FTY720 in vaginal tissues.

Tsuiki A, Luo W, Henning T, Vishwanathan S, Dinh C, Adams D, Sweeney E, Mitchell J, Bachman S, Sharma P, Powell N, Hendry M, McNicholl J, Kersh E.

J Med Primatol. 2013 Apr;42(2):89-100. doi: 10.1111/jmp.12033. Epub 2013 Jan 12.

PMID:
23311598
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis.

Johnson TJ, Clark MR, Albright TH, Nebeker JS, Tuitupou AL, Clark JT, Fabian J, McCabe RT, Chandra N, Doncel GF, Friend DR, Kiser PF.

Antimicrob Agents Chemother. 2012 Dec;56(12):6272-83. doi: 10.1128/AAC.01431-12. Epub 2012 Sep 24.

PMID:
23006751
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

RMP-02/MTN-006: A phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil fumarate.

Anton PA, Cranston RD, Kashuba A, Hendrix CW, Bumpus NN, Richardson-Harman N, Elliott J, Janocko L, Khanukhova E, Dennis R, Cumberland WG, Ju C, Carballo-DiƩguez A, Mauck C, McGowan I.

AIDS Res Hum Retroviruses. 2012 Nov;28(11):1412-21. doi: 10.1089/AID.2012.0262. Epub 2012 Oct 9.

PMID:
22943559
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females.

Tan D.

Int J Womens Health. 2012;4:341-50. doi: 10.2147/IJWH.S27601. Epub 2012 Jul 19.

PMID:
22927765
[PubMed]
Free PMC Article
13.

What primary care providers need to know about preexposure prophylaxis for HIV prevention: a narrative review.

Krakower D, Mayer KH.

Ann Intern Med. 2012 Oct 2;157(7):490-7. Review.

PMID:
22821365
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

HIV incidence in young girls in KwaZulu-Natal, South Africa--public health imperative for their inclusion in HIV biomedical intervention trials.

Abdool Karim Q, Kharsany AB, Frohlich JA, Werner L, Mlotshwa M, Madlala BT, Abdool Karim SS.

AIDS Behav. 2012 Oct;16(7):1870-6.

PMID:
22618892
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Reformulated tenofovir gel for use as a dual compartment microbicide.

Dezzutti CS, Rohan LC, Wang L, Uranker K, Shetler C, Cost M, Lynam JD, Friend D.

J Antimicrob Chemother. 2012 Sep;67(9):2139-42. doi: 10.1093/jac/dks173. Epub 2012 May 11.

PMID:
22581908
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The importance of the vaginal delivery route for antiretrovirals in HIV prevention.

Ferguson LM, Rohan LC.

Ther Deliv. 2011 Dec;2(12):1535-50. doi: 10.4155/tde.11.126. Review.

PMID:
22468220
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Characterization of UC781-tenofovir combination gel products for HIV-1 infection prevention in an ex vivo ectocervical model.

Cost M, Dezzutti CS, Clark MR, Friend DR, Akil A, Rohan LC.

Antimicrob Agents Chemother. 2012 Jun;56(6):3058-66. doi: 10.1128/AAC.06284-11. Epub 2012 Mar 19.

PMID:
22430977
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection.

Gengiah TN, Baxter C, Mansoor LE, Kharsany AB, Abdool Karim SS.

Expert Opin Investig Drugs. 2012 May;21(5):695-715. doi: 10.1517/13543784.2012.667072. Epub 2012 Mar 7. Review.

PMID:
22394224
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The Promise of Antiretrovirals for HIV Prevention.

Flash C, Krakower D, Mayer KH.

Curr Infect Dis Rep. 2012 Apr;14(2):185-93. doi: 10.1007/s11908-012-0242-z.

PMID:
22351302
[PubMed]
Free PMC Article
20.

Sensitive and rapid HPLC quantification of tenofovir from hyaluronic acid-based nanomedicine.

Agrahari V, Youan BB.

AAPS PharmSciTech. 2012 Mar;13(1):202-10. doi: 10.1208/s12249-011-9735-6. Epub 2012 Jan 4.

PMID:
22215290
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk